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The epidermis is a barrier tissue that is exposed to the environment and susceptible to injury. Cooperation between epithelial cells, growth factors, chemokines, and inflammatory cells leads to rapid repair of most injuries. However, in creasing numbers of patients suffer from chro nic, nonhealing wounds (1) . Although much is known about processes leading to effective tissue repair, the role of human epithelial-resident T cells in wound healing has not been examined.  + T cells are found in both the epidermis and dermis of human skin (2) (3) (4) . In contrast to ro dents, there is also a major resident population of epidermal  + T cells (5) . Other than analy sis of their presence, little is known about these human skin-resident T cell populations. The T cell compartment in mouse epidermis is exclu sively composed of  + T cells, with invariant TCRs designated as dendritic epidermal T cells (DETCs) (6) . These cells are critical for tumor immunosurveillance (7) , skin homeostasis (8) , and wound repair (9) . Identification of a hu man skin T cell equivalent with specialized wound healing properties would provide crucial insight into the mechanism of effective repair of acute wounds and elucidate new targets for therapeutic intervention in the treatment of chronic wounds. In this report, we show that human epidermal  + and  + T cells contrib ute to the effective healing of acute wounds and are functionally defective in patients with chronic wounds, demonstrating a previously unrecognized component of human epidermal wound healing.
RESULTS AND DISCUSSION V1 and  TCR-bearing cells reside in normal human epidermis
Before examining a role for  + and  + T cells in wound repair and homeostasis, we first investigated the presence of T cell populations in healthy human epidermis. We used a classical Epidermal T cells have been shown to play unique roles in tissue homeostasis and repair in mice through local secretion of distinct growth factors in the skin. Human epidermis contains both  + and  + T cells whose functional capabilities are not understood. We demonstrate that human epidermal T cells are able to produce insulin-like growth factor 1 (IGF-1) upon activation and promote wound healing in a skin organ culture model. Moreover, an analysis of the functional capabilities of T cells isolated from acute versus chronic wounds revealed a striking difference. Both  + and V1 + T cells isolated from acute wounds actively produced IGF-1, demonstrating that they are activated during tissue damage to participate in wound repair. In contrast, IGF-1 production could not be detected in T cells isolated from chronic wounds. In fact, skin T cells isolated from chronic wounds were refractory to further stimulation, suggesting an unresponsive state. Collectively, these results define a novel role for human epidermis-resident T cells in wound healing and provide new insight into our understanding of chronic wound persistence. cells in peripheral blood express the V2 chain (10) . Indeed, V1 + T cells, but not V2 + cells, were found in the dermis and epidermis of patient skin samples (unpublished data). We therefore used an antiV1 antibody for the detection of  + T cells resident in the skin. We detected a substantial number of V1 + T cells compared with  + T cells in the epidermis and dermis compared with the blood, in which the  T cell popu lation is mainly composed of V2 + T cells (Fig. 1 , A and C) (11) . Cutaneous leukocyte antigen (CLA), the ligand for method to isolate T cells from the skin (3) that offered the ad vantage of separating epidermis from dermis, and the ability to study freshly isolated cells. This was especially useful for inves tigating growth factor production by T cells in wounded skin, a characteristic that might be affected by culturing the T cells or using skin explants (4). Epidermal and dermal T cells were studied and compared with peripheral T cells from healthy donors. It has been previously reported that  + T cells in ep ithelial tissues primarily express the V1 chain, whereas  + T 
BRIEF DEFINITIVE REPORT
cific for CD3 (5 µg/ml OKT3). After 2 d, T cell activation was measured by an increase in cellsurface expression of the IL2 receptor  chain, CD25, on  + and V1 + T cells by flow cytometry. We observed an upregulation of cell surface CD25 expression by both  + and V1 + T cells (Fig. 3 B) , demonstrating activation of both T cells subsets. Significantly, addition of antiCD3 accelerated the wound closure rate at an early stage (days 0-2) compared with un treated skin (Fig. 3 C) . Collectively, these data indicate that TCRspecific activation of resident T cells promotes wound healing at an early stage.
To identify whether T cell-produced IGF1 is responsible for the improved wound closure, we attempted to block T cell-mediated IGF1 responses using IGF1 receptor (IGF1R) antibody after antiCD3 stimulation in skin organ culture. Wound closure was measured between days 0 and 2, because the effect of T cell activation was maximal at this early stage. As shown in Fig. 3 D, antiCD3 stimulation increases the rate of wound closure. Addition of an anti-IGF1R antibody significantly blocks this effect, demonstrating that T cellmediated wound closure is dependent on IGF1.
Eselectin that is expressed by endothelial cells, is also present on dermalresident T cells (4) . We found that epidermal  + and V1 + T cells express high levels of CLA compared with T cells isolated from the blood (Fig. 1, A and B ). There was no significant difference between the epidermis and dermis in terms of CLA expression in the  + and V1 + subsets ( Fig. 1 B) , whereas CD28 expression was limited to CLA + , CD3 + ,  + T cells (not depicted). Overall, our results indi cate that human skin contains epidermalresident  + and  + T cells that have the potential to function in immune sur veillance in the skin.
Resident epidermal T cells produce insulin-like growth factor 1 (IGF-1)
We recently showed that mouse DETCs regulate skin ho meostasis through the secretion of IGF1 (8), a member of the insulin family of growth hormones. IGF1 is used by ke ratinocytes in the skin for epidermal development and main tenance (12) . In human skin, IGF1 regulates keratinocyte shape and migration for the mediation of wound epitheliali zation (13) . Fibroblasts have been suggested to be the main IGF1 source in the skin (14) . To investigate whether human epidermal T cells can contribute to this aspect of wound re pair, human T cells were isolated from the epidermis of nor mal skin and assessed for IGF1 production by flow cytometry. Skin from 17 healthy donors was examined. For each donor, epidermal cells were incubated with Brefeldin A for 6 h in the presence or absence of PMA and ionomycin. We found that epidermal  + and V1 + T cells constitutively produce IGF1 at low levels ( Fig. 2) , as previously described for mouse DETCs (8) . Moreover, we observed a significant threefold increase of IGF1 production by skinresident T cells upon stimulation (Fig. 2 B) . No correlation between donor age and IGF1 production was observed (r < 0.8). Interestingly, previous studies have shown that levels of IGF1 are increased after epidermal injury, peaking at 3 d after wounding (15) , and IGF1 in human wound fluid reaches maximum levels within 24 h after injury (16) . Collectively, our results dem onstrate that human skin T cells are a previously unrecog nized local source of IGF1 in the epidermis and have the capacity to upregulate growth factor expression upon acti vation, which may affect wound repair.
Specific T cell stimulation promotes wound healing
To examine the participation of skinresident T cells in the reepithelialization phase of wound repair, we used a well defined model of in vitro skin organ culture (16) . Because human lymphocytes have not been studied in this model, we first showed that epidermalresident T cells do not mi grate out of the skin during the first 2 d of culture, and demonstrated that  + and V1 + cells remain functional upon in vitro stimulation by examining IFN production (Fig. 3 A) . Next, we directly stimulated resident T cells in situ with an antiCD3 antibody in skin organ cultures, as previously described for cells in the small intestine (17) . Human skin was cultured with or without an antibody spe have been shown to be decreased in nonhealing wounds from diabetic patients (18) . We therefore hypothesized that skinresident T cells are activated upon injury in vivo to pro duce IGF1. We investigated IGF1 expression in  + and V1 + T cells from acute wounds. Skin specimens from patients suffering from recent injury were used to study IGF1 production in the context of acute wounds. Cells were iso lated from acute wounds and examined for IGF1 produc tion by flow cytometry. Levels of IGF1 produced by both  + and V1 + T cells from wounded skin were similar to IGF1 levels in T cells stimulated with PMA and ionomycin (Fig. 4 B) . In addition to PMA and ionomycin, antiCD3-stimulating antibody induced IGF1 production in T cells, whereas IL2 treatment did not (unpublished data). This data implies that T cells upregulate IGF1 in response to tissue injury, which likely promotes wound repair.
To determine if this is a unique response of skinresident T cells during injury,  + and V1 + T cells were isolated from the blood of both normal healthy donors and from acutely wounded patients 2-7 d after surgery. Basal IGF1
T cells are activated after acute injury but are functionally impaired in chronic wounds Several pathogenic abnormalities contribute to failure to heal, and the progression of the healing process is impaired in chronic wounds. We therefore hypothesized that T cells might be reduced in number or functionally defective in patients af fected by chronic wounds. Skin samples (n = 8) from patients exhibiting wounds that had failed to heal within 8 wk were used to study the presence and function of T cells in chronic wounds, as compared with patients with acute wounds healing normally. No significant differences were found in the ratio of  + to V1 + T cells in chronic as compared with acute wounds (Fig. 4 A) . Analysis of absolute cell numbers found an average of 2,890  and 283 V1 T cells/cm 2 in normal epidermis, and an average of 10,860  and 300 V1 T cells/cm 2 in acute and chronic wounds. These data suggest that there is a recruit ment of primarily  T cells to wound sites, whereas the V1 T cells found in wounds are a skinresident population.
One of the hallmarks of the early stage of wound repair is increased IGF1 at the wound site, and levels of IGF1 
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However, an analysis of the functional capabilities of T cells isolated from chronic versus acute wounds revealed a striking difference. Both  + and V1 + T cells isolated from nonhealing chronic skin wounds did not produce IGF1 compared with T cells isolated from acute wounds (Fig. 4,  B and D) . No significant differences were observed in CD69 expression on  and V1 T cells from patients with chronic wounds (n = 4) compared with normal epidermis (n = 4; not depicted). This indicates that, although present, T cells in levels were similar between T cells isolated from the acutely wounded patients as compared with the normal healthy do nors. We observed a small but not statistically significant in crease in the wounded patients that may represent  + or V1 + T cells that have exited the wound site. In all cases, IGF1 levels were increased upon ex vivo stimulation with PMA and ionomycin. Our data suggests that upregulated T cell production of IGF1 during wound repair is limited to the local environment (Fig. 4 C) . that debridement, often an effective treatment for resolving chronic wounds, could aid in the release of trapped growth factors unavailable for wound healing. Moreover, the hypoth esis that debridement resets the stage for wounds proceeding toward the normal sequence of healing (20) is supported by patient 4 (Fig. 4 B) from our acute wound group. This patient received a first debridement surgery 3 d before our detection of high T cell specific IGF1 production.
Cutaneous wound healing is a complex process requiring constant communication between cells in the form of cyto kine release, celltocell contacts, and celltomatrix interac tions. Chronic wounds are a serious clinical problem affecting numerous elderly and diabetic patients. Many cell types are involved in wound healing, but the role of resident T cells has been neglected. This report demonstrates for the first time that skinresident T cell populations ( + and V1 + ) are able to produce IGF1, which can contribute to skin homeo stasis and promote wound healing. It will now be important to define the trigger of  + and V1 + T cell activation in acute wounds and address the mechanism of dysregulation of T cell-mediated wound repair in chronic wounds. Some of chronic wounds are functionally impaired and are unable to produce IGF1 during the tissue repair process.
Epidermal T cells from chronic wounds are less responsive to stimulation
To better characterize whether skinresident T cells in chronic wounds retain the ability to produce IGF1 and cytokines upon stimulation, we isolated  + and V1 + T cells from the epidermis of normal and chronic wounds, and stimulated them in vitro for 6 h with PMA and ionomycin. As shown in Fig. 5 A, neither  + or V1 + T cells isolated from chronic wounds could be restored by stimulation with PMA and ion omycin (Fig. 5 A) . Additionally,  + and V1 + T cells iso lated from chronic wounds produce significantly less IL2 after stimulation compared with cells isolated from normal epidermis (Fig. 5 B) . This suggests that the T cells in a chronic wound environment become less responsive to activation.
Collectively, these data indicate that T cells are function ally impaired in chronic wounds, and bypassing TCR stimu lation is unable to rescue function. These data are in line with the hypothesis proposed by Falanga et al. (19) , which states 
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CD25 (0479) was purchased from Beckman Coulter. Analysis of flow cytom etry samples was performed on a FACSCalibur or an LSRII (both from BD). Data were analyzed with FlowJo software (Tree Star, Inc.).
Skin organ culture. Skin organ culture was performed as previously de scribed (23) using human foreskin samples. This method can be effectively used to examine keratinocyte proliferation and migration during the reepithe lialization phase of wound repair. In brief, each sample was trimmed into four pieces with a 6mm diameter each, and a punch biopsy with a 3mm diameter including the epidermis and upper dermis was removed from the center. Each piece was placed with the dermis down on gelfoam (Savmart Pharmaceuticals) in a 24well plate containing DMEM/10% FCS in the presence or absence of an antiCD3 antibody (5 µg/ml OKT3; eBioscience) or the isotype control. These cultures were incubated at 37°C with 5% CO 2 for 5 d, with the media changed every other day. For blocking experiments, 12 µg/ml IGF1 receptor antibody (R&D Systems) was added to skin organ cultures. Digital images were acquired every day, and the wound surface area was measured and analyzed with ImageJ software (available at http://rsbweb.nih .gov/ij/). For each experiment, two to three foreskin samples were processed. To address T cell activation (CD25 expression and IFN production) after 2 d of culture, healthy skin specimens were used and processed as described.
Statistical analysis. Data were analyzed using an unpaired Student's t test to determine significant differences between two groups of patients and a paired t test to determine significant differences within the same group. Tests were twotailed except when noted in the text. All findings were considered signif icant at P < 0.05. Power analysis based on previous mouse cell work indicated that a minimum sample size of two provided power of >95% at  = 0.05. Table S1 shows the main features of the subjects with wounds presented in Fig. 4 . Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20081787/DC1. the healthy patients examined in this study did exhibit a low level of IGF1 production by resident T cells after stimula tion. It is possible that this phenotype, in addition to chronic disease such as diabetes, increases susceptibility to chronic wounds. On the other hand, perhaps activating antigens are masked or overstimulate the T cells in a chronic wound, leading to their unresponsiveness to activation signaling. T cell dysfunc tion might also be caused by increased expression of inhibitory receptors such as programmed death 1, which have been shown to become elevated in response to severe injury (21) and HIV infection (22) . From a clinical aspect, T cell impairment at an early stage of the wound healing process could be a predictive factor for chronic wound formation. In addition, these results may explain why wound debridement is often effective for the treatment of chronic wounds. This new evidence supports the idea that skinresident T cells play a critical role in skin homeo stasis and the wound repair mechanism in humans, suggesting possible therapeutic targets that could be considered in the fu ture to enhance chronic wound management.
Online supplemental material.

MATERIALS AND METHODS
Subjects.
Acquisition of skin samples and all scientific studies were ap proved by the Institutional Review Boards of Scripps Health and the Uni versity of California, San Diego. Informed consent was obtained from all subjects. Samples of normal human skin and wounded skin were obtained from discarded human tissue from cutaneous surgery. Skin specimens from patients suffering from recent injury were used to study acute wounds. None of the patients had systemic disease or were currently receiving immuno suppressive treatment. Discarded tissue from patients affected by wounds that failed to heal within 2 mo was used to study chronic wounds. More details on patients enrolled in the study are given in Table S1 . Foreskin was ob tained from the Cooperative Human Tissue Network for use in skin organ culture. Normal human blood was obtained from the Scripps Research In stitute Normal Blood Donor Services. Blood samples from patients after breast reduction surgery (2-7 d) were used to investigate IGF1 production by T cells from acutely wounded patients.
Cell isolation. Separation of the epidermis and dermis was accomplished by floating small skin strips on 1.25 U/ml Dispase II solution (Roche) overnight at 4°C. Epidermal sheets were separated from the dermis by me chanical separation and vigorously agitated in fresh Dispase II for 30 min at 37°C. The dermis was further treated with 1 mg/ml collagenase D (Roche) and Dispase II for 30 min at 37°C, isolating T cells from the dermis. Wounded skin was processed according to the same enzymatic digestion: Dispase II overnight at 4°C followed by Dispase II and collagenase D for 30 min at 37°C. Digestion was halted by the addition of 10 mM EDTA. Cell suspensions were filtered, enriched for T cells using a FicollPaque gradient, and rested in complete medium (RPMI 1640, 10% FCS, 25 mM Hepes, 100 U penicillin, 100 µg streptomycin, 2 mM glutamine, 100 µM of nonessential amino acids, 1 mM sodium pyruvate) for 6 h. To assess IGF1 production, cells were cultured in the presence or absence of 50 ng/ml PMA and 500 ng/ml ionomycin, and 5 µg/ml Brefeldin A (SigmaAldrich) for 6 h. Cells were fixed and permeabilized with Fix & Perm reagent (Invitrogen) according to manufacturer's instructions.
Flow cytometry. Antibodies to IGF1 (G17) and the accompanying block ing peptides were purchased from Santa Cruz Biotechnology, Inc. Secondary antibody-staining reagents were purchased from Jackson ImmunoResearch Laboratories. mAbs to CD3 (UCHT1),  (T10B9.1A31), V2 (B6), and CLA (HECA452) were obtained from BD, and mAbs to CD3 (UCHT1),  (IP26), and IFN (4S.B3) were purchased from eBioscience. The mAb to V1 (TS8.2) was obtained from Thermo Fisher Scientific, and the mAb to
